Skip to main content
  • Clariant Logo
  • Share
  • Contact
  • en - US
  • Translate
  • Contrast
  • Search
  • Products & Industries
  • Sustainability
  • Company
  • Media
  • Investors
  • Careers
  • Events
Close
Search
Close
SDS & Document Finder
result(s)
All Results
Close
Facebook Twitter LinkedIn E-Mail WhatsApp More Options
Close
Close
The translation will be performed automatically using AI. Please double-check important facts and statements.
Close
Clariant International
  • Products & Industries
  • Sustainability
  • Company
  • Media
  • Investors
  • Careers
  • Events
Home / Clariant Specialty Chemicals / Clariant news / Clariant rejects Dow Europe’s allegations against …
News
Summarize
May 12, 2025

Clariant rejects Dow Europe’s allegations against four companies related to the 2020 competition law infringement

Ad hoc announcements pursuant to Art. 53 LR Corporate Global

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Muttenz, 12 May 2025 – Clariant, a sustainability-focused specialty chemical company, today announced that on 9 May 2025, the company received a claim for damages against four companies, including Clariant, from Dow Europe with the court of Munich, Germany. The claim alleges damages totaling to around EUR 767 million in relation to infringement of competition law on the ethylene purchasing market which was sanctioned by the European Commission in July 2020. Clariant firmly rejects the allegation and will adamantly defend its position in the proceedings. Dow Europe was not a supplier of ethylene to Clariant and Clariant has substantiated economic evidence that the conduct of the parties did not produce any effect on the market.


Documents

  • Ad hoc Release Rejection of Dow Damage Claim 20250512 EN (0.11 MB)
Read all news
Clariant International
          Clariant International
          We at Clariant are aware of our responsibility. Our purpose »Greater chemistry – between people and planet« describes the role we can play in the world if we align our thinking and all future decisions with it.
          Social
          • Imprint
          • Terms of Use
          • Data protection and privacy
          • General Terms and Conditions of Sale and Purchase
          Copyright © Clariant 2026. All rights reserved.

          Page summary

          close
          Summarization in progress
          The page summary is generated by AI